Jakob Fuhrmann

Principal Sientist

Jakob Fuhrmann is a Principal Scientist at Genentech, where he leads a chemical biology group in the field of peptide and peptidomimetic drug discovery. He received his PhD from the University of Vienna, Austria, where he discovered protein arginine phosphorylation as a new type of post-translational modification. He performed his postdoctoral studies in chemistry at the Scripps Research Institute generating novel small-molecule inhibitors and probes against a variety of targets. He has extensive experience in medicinal chemistry, structural biology (including targeted protein degradation), structure-guided designs, as well as property-based lead optimization. Jakob holds a number of patents, and is author of several high-impact publications across different drug modalities.

Talks About
#ChemicalBiology #StructuralBiology

Preferred Locations
#NorthAmerica